Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease. [PDF]
Dwomoh L, Tejeda GS, Tobin AB.
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis+16 more
wiley +1 more source
Pharmacological Profiling of a Brugia malayi Muscarinic Acetylcholine Receptor as a Putative Antiparasitic Target. [PDF]
Gallo KJ+4 more
europepmc +1 more source
Predicting novel pharmacological activities of compounds using PubChem IDs and machine learning (CID-SID ML model) [PDF]
Significance and Object: The proposed methodology aims to provide time- and cost-effective approach for the early stage in drug discovery. The machine learning models developed in this study used only the identification numbers provided by PubChem.
arxiv
The binding of pirenzepine to digitonin‐solubilized muscarinic acetylcholine receptors from the rat myocardium [PDF]
N.J.M. Birdsall+2 more
openalex +1 more source
Abstract Objective Acute organophosphate (OP) intoxication affects a significant number of individuals worldwide. Those who survive OP‐induced cholinergic crisis, which includes status epilepticus, often develop neurological morbidities. Here, we provide a rigorous characterization of the acute and delayed electrophysiological responses to OP ...
Jeremy A. MacMahon+8 more
wiley +1 more source
A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling. [PDF]
Xu R+6 more
europepmc +1 more source
Immunologic mimicry by a monoclonal antibody of the tricyclic anti-depressants' binding site on muscarinic acetylcholine receptors. [PDF]
Stéfano Marullo+4 more
openalex +1 more source
Succinate receptor 1 signaling mutually depends on subcellular localization and cellular metabolism
SUCNR1, activated by succinate, is a Gi‐ and Gq‐coupled receptor present at the plasma membrane and in endosomes. There are conflicting reports about the pro‐/anti‐inflammatory effects of the succinate‐SUCNR1 signaling axis, and these are likely due to localization‐dependent signaling.
Aenne‐Dorothea Liebing+11 more
wiley +1 more source